Finance

Beta
Lists
41L:FRA
Laboratorios Farmaceuticos ROVI SA
€57.70
-0.86%
(-0.50) 1D
Jun 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 41L...
Open
€57.60
High
€57.70
Low
€57.60
Mkt. cap
2.94B
Avg. vol.
9.00
Volume
4.00
Dividend
1.66%
Quarterly dividend
€0.24
Ex-dividend date
Jul 13, 2026
P/E ratio
22.41
52-wk high
€85.65
52-wk low
€52.30
EPS
€2.57
No. of employees
2K
Open
€57.60
High
€57.70
Low
€57.60
Mkt. cap
2.94B
Avg. vol.
9.00
Volume
4.00
Dividend
1.66%
Quarterly dividend
€0.24
Ex-dividend date
Jul 13, 2026
P/E ratio
22.41
52-wk high
€85.65
52-wk low
€52.30
EPS
€2.57
No. of employees
2K
News stories
From sources across the web
About Laboratorios Farmaceuticos ROVI SA
CEO-
Employees2K
Founded1946
Headquarters-
SectorPharmaceutical industry
Websiterovi.es
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
159.70M
210.47M
218.42M
152.49M
Cost of goods sold
54.41M
62.66M
90.33M
59.61M
Cost of revenue
54.41M
62.66M
90.33M
59.61M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.32M
34.66M
55.40M
38.04M
Operating expense
77.92M
79.83M
73.16M
83.00M
Total operating expenses
132.33M
142.49M
163.49M
142.61M
Operating income
27.37M
67.98M
54.93M
9.89M
Other non operating income
111.00K
8.35M
3.80M
2.32M
EBT including unusual items
26.78M
75.70M
57.94M
12.29M
EBT excluding unusual items
26.78M
75.70M
57.94M
12.29M
Income tax expense
5.15M
17.68M
15.29M
2.84M
Effective tax rate
19.24%
23.36%
26.39%
23.11%
Other operating expenses
35.13M
37.70M
9.61M
36.79M
Net income
21.64M
58.03M
42.68M
9.48M
Net profit margin
13.55%
27.57%
19.54%
6.22%
Earnings per share
-
-
-
-
Interest and investment income
139.00K
86.00K
-
403.00K
Interest expense
-699.00K
-757.00K
-767.00K
-782.00K
Net interest expenses
-560.00K
-671.00K
-767.00K
-379.00K
Depreciation and amortization charges
7.47M
7.47M
8.16M
8.17M
EBITDA
31.08M
79.21M
55.10M
18.05M
Gain or loss from assets sale
-
-
14.00K
1.77M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more